Merck Leads Health Care's Bounce as the Dow Jumps Almost 200 Points
Johnson & Johnson and Merck rank among the Dow's leaders on a great day for investors across the markets.
Regeneron Pharmaceuticals' Q4 Profit Surges 51% on Strong Eylea Sales
Impressive Eylea sales growth within and outside the U.S., as well as increased collaborative revenue, pushes Regeneron's profit up 51%.
Today’s Top Biotech Stories: Mallinckrodt, Regeneron, Arena, and Omeros
Mallinckrodt, Regeneron, Arena, and Omeros could all loom large in health care headlines this morning. Here’s why.